Work

Genetic variants in immune response genes to predict clinical outcome in mCRC patients treated with FOLFIRI/cetuximab (FIRE-3) or with first line cetuximab-based chemotherapy (JACCRO CC-05/06 AR).

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.3595

Authors: Jordan David West, Wu Zhang, Sebastian Stintzing, Yu Sunakawa, Dongyun Yang, Shu Cao, Yan Ning, Martin D. Berger, Roel Gopez, Yuji Miyamoto, Satoshi Okazaki, Mitsukuni Suenaga, Marta Schirripa, Afsaneh Barzi, Diana L. Hanna, Akihito Tsuji, Wataru Ichikawa, Volker Heinemann, Heinz-Josef Lenz

Institutions: University of Southern California, USC Norris Comprehensive Cancer Center, Ludwig-Maximilians-Universität München, SHOWA Medical University Northern Yokohama Hospital, Kagawa University, SHOWA Medical University Fujigaoka Hospital

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2890184124

Cites:

Cited by:

Related to: 10